← Open Payments lookup

SHERRY BROWN: Open Payments

NPI 1952829475 · JONESBORO, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,445 in 82 payments from 19 companies in 2025. Trend: 2023 $912 · 2024 $1,481 · 2025 $1,445

Food & beverage: $1,445
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP18$338
Sumitomo Pharma America, Inc.10$175
ABBVIE INC.11$160
Boehringer Ingelheim Pharmaceuticals, Inc.5$92
Novo Nordisk Inc5$90
Phathom Pharmaceuticals, Inc.8$82
Salix Pharmaceuticals, a division of Bausch Health US, LLC4$77
Otsuka America Pharmaceutical, Inc.3$74
Lilly USA, LLC4$64
Novartis Pharmaceuticals Corporation2$51

Products named: AIRSUPRA, GEMTESA, FARXIGA, VOQUEZNA, REXULTI, MOUNJARO, UBRELVY, Ozempic.

Industry payments across AR — which companies pay providers there.